{"id":"https://openalex.org/W2139682456","doi":"https://doi.org/10.1186/s13561-014-0032-4","title":"Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany","display_name":"Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany","publication_year":2014,"publication_date":"2014-11-22","ids":{"openalex":"https://openalex.org/W2139682456","doi":"https://doi.org/10.1186/s13561-014-0032-4","mag":"2139682456","pmid":"https://pubmed.ncbi.nlm.nih.gov/26208932","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4502064"},"language":"en","primary_location":{"id":"doi:10.1186/s13561-014-0032-4","doi":"https://doi.org/10.1186/s13561-014-0032-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13561-014-0032-4","pdf_url":"https://healtheconomicsreview.biomedcentral.com/counter/pdf/10.1186/s13561-014-0032-4","source":{"id":"https://openalex.org/S2738551320","display_name":"Health Economics Review","issn_l":"2191-1991","issn":["2191-1991"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["abdc-c","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics Review","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://healtheconomicsreview.biomedcentral.com/counter/pdf/10.1186/s13561-014-0032-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Sarah Neubauer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114112103","display_name":"Leibniz University Hannover","ror":"https://ror.org/0304hq317","country_code":"DE","type":"education","lineage":["https://openalex.org/I114112103"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Sarah Neubauer","raw_affiliation_strings":["Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Otto-Brenner-Stra\u00dfe 1, D-30159, Hannover, Germany, sn@ivbl.uni-hannover.de","Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Otto-Brenner-Stra\u00dfe 1, D-30159, Hannover, Germany, sn@ivbl.uni-hannover.de","institution_ids":["https://openalex.org/I114112103"]},{"raw_affiliation_string":"Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Hannover, Germany","institution_ids":["https://openalex.org/I114112103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109962019","display_name":"Mary A. Cifaldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Cifaldi","raw_affiliation_strings":["AbbVie Inc, North Chicago, IL, USA","Abbvie Inc, North Chicago, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Abbvie Inc, North Chicago, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074188740","display_name":"Thomas Mittendorf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Mittendorf","raw_affiliation_strings":["Herescon GmbH, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herescon GmbH, Hannover, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108653084","display_name":"Arijit X. Ganguli","orcid":"https://orcid.org/0009-0000-2569-2734","observed_orcids":["https://orcid.org/0009-0000-2569-2734"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arijit Ganguli","raw_affiliation_strings":["AbbVie Inc, North Chicago, IL, USA","Abbvie Inc, North Chicago, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Abbvie Inc, North Chicago, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015424633","display_name":"Malte Wolff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malte Wolff","raw_affiliation_strings":["AbbVie Inc, North Chicago, IL, USA","Abbvie Inc, North Chicago, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Abbvie Inc, North Chicago, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091517921","display_name":"Jan Zeidler","orcid":"https://orcid.org/0000-0002-0104-2267","observed_orcids":["https://orcid.org/0000-0002-0104-2267"]},"institutions":[{"id":"https://openalex.org/I114112103","display_name":"Leibniz University Hannover","ror":"https://ror.org/0304hq317","country_code":"DE","type":"education","lineage":["https://openalex.org/I114112103"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jan Zeidler","raw_affiliation_strings":["Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Otto-Brenner-Stra\u00dfe 1, Hannover, D-30159, Germany","Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Otto-Brenner-Stra\u00dfe 1, Hannover, D-30159, Germany","institution_ids":["https://openalex.org/I114112103"]},{"raw_affiliation_string":"Center for Health Economics Research Hannover (CHERH), Leibniz Universit\u00e4t Hannover, Hannover, Germany","institution_ids":["https://openalex.org/I114112103"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114112103"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":2.0857,"has_fulltext":true,"cited_by_count":35,"citation_normalized_percentile":{"value":0.85892829,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"4","issue":"1","first_page":"32","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9700000286102295},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9990000128746033},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":1.0},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.9779999852180481},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.5389999747276306},{"id":"https://openalex.org/keywords/health-insurance-claims-data","display_name":"health insurance claims data","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.956082820892334},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.9530357122421265},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.9144007563591003},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8720937967300415},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7565176486968994},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6363070011138916},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.49982428550720215},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.2981663644313812},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.1186/s13561-014-0032-4","doi":"https://doi.org/10.1186/s13561-014-0032-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13561-014-0032-4","pdf_url":"https://healtheconomicsreview.biomedcentral.com/counter/pdf/10.1186/s13561-014-0032-4","source":{"id":"https://openalex.org/S2738551320","display_name":"Health Economics Review","issn_l":"2191-1991","issn":["2191-1991"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["abdc-c","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics Review","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4502064","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4502064","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Econ Rev","raw_type":"Text"},{"id":"pmid:26208932","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26208932","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health economics review","raw_type":"Journal Article"},{"id":"pmh:oai:repo.uni-hannover.de:123456789/987","doi":null,"is_oa":true,"landing_page_url":"https://repo.uni-hannover.de/handle/123456789/987","pdf_url":null,"source":{"id":"https://openalex.org/S4306401575","display_name":"Institutional Repository of Leibniz Universit\u00e4t Hannover (Leibniz Universit\u00e4t Hannover)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114112103","host_organization_name":"Leibniz University Hannover","host_organization_lineage":["https://openalex.org/I114112103"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics Review 4 (2014)","raw_type":"doc-type:Article"},{"id":"pmh:oai:econstor.eu:10419/150437","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10419/150437","pdf_url":null,"source":{"id":"https://openalex.org/S4306401696","display_name":"Econstor (Econstor)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"doc-type:article"},{"id":"pmh:oai:www.repo.uni-hannover.de:123456789/987","doi":null,"is_oa":true,"landing_page_url":"http://www.repo.uni-hannover.de/handle/123456789/987","pdf_url":null,"source":{"id":"https://openalex.org/S4306401575","display_name":"Institutional Repository of Leibniz Universit\u00e4t Hannover (Leibniz Universit\u00e4t Hannover)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114112103","host_organization_name":"Leibniz University Hannover","host_organization_lineage":["https://openalex.org/I114112103"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Economics Review 4 (2014)","raw_type":"doc-type:Article"},{"id":"doi:10.15488/963","doi":"https://doi.org/10.15488/963","is_oa":true,"landing_page_url":"https://doi.org/10.15488/963","pdf_url":null,"source":{"id":"https://openalex.org/S7407052956","display_name":"Leibniz Universit\u00e4t Hannover","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1186/s13561-014-0032-4","doi":"https://doi.org/10.1186/s13561-014-0032-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13561-014-0032-4","pdf_url":"https://healtheconomicsreview.biomedcentral.com/counter/pdf/10.1186/s13561-014-0032-4","source":{"id":"https://openalex.org/S2738551320","display_name":"Health Economics Review","issn_l":"2191-1991","issn":["2191-1991"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["abdc-c","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Economics Review","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139682456.pdf","grobid_xml":"https://content.openalex.org/works/W2139682456.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W135238469","https://openalex.org/W186776021","https://openalex.org/W1558329586","https://openalex.org/W1966439074","https://openalex.org/W1979300931","https://openalex.org/W2019460882","https://openalex.org/W2036135039","https://openalex.org/W2036968899","https://openalex.org/W2057665750","https://openalex.org/W2061326496","https://openalex.org/W2062697678","https://openalex.org/W2068616072","https://openalex.org/W2087204357","https://openalex.org/W2088684279","https://openalex.org/W2097730524","https://openalex.org/W2109268320","https://openalex.org/W2114270885","https://openalex.org/W2139126390","https://openalex.org/W2139525798","https://openalex.org/W2142632855","https://openalex.org/W2145199583","https://openalex.org/W2148201023","https://openalex.org/W2148692760","https://openalex.org/W2150703501","https://openalex.org/W2158003651","https://openalex.org/W2223868808","https://openalex.org/W2423091708","https://openalex.org/W2607079988","https://openalex.org/W2992160256","https://openalex.org/W3041047318","https://openalex.org/W4234127366","https://openalex.org/W4308769923"],"related_works":["https://openalex.org/W2012128103","https://openalex.org/W2754573378","https://openalex.org/W2142632855","https://openalex.org/W2329212825","https://openalex.org/W2549438849","https://openalex.org/W2983644444","https://openalex.org/W4404427965","https://openalex.org/W2039095216","https://openalex.org/W4399482778","https://openalex.org/W2801927259"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"obtain":[2],"detailed":[3],"real-world":[4],"data":[5,37],"on":[6,117],"persistence":[7,80,159,174,196,223,258],"and":[8,20,47,64,112,142,164,170,186,208,215,233,238,241,262],"dosing":[9],"patterns":[10],"in":[11,22,28,119,156,228,244,257],"the":[12,15,75,85,157,195,222,245,280],"utilisation":[13],"of":[14,38,57,77,127,134],"TNF":[16,78,138,147,167],"inhibitors":[17],"adalimumab,":[18,58,110,162,182,204,230,260],"etanercept,":[19,207,232],"infliximab":[21,61,165,189,235,263,277],"rheumatoid":[23],"arthritis":[24],"(RA)":[25],"patients":[26,130,136,141,237],"treated":[27,264],"Germany.":[29],"METHODS:":[30],"In":[31,249],"this":[32,250],"retrospective":[33],"observational":[34],"study":[35],"claims":[36],"a":[39,81,272],"major":[40],"German":[41],"health":[42],"insurance":[43],"fund":[44],"between":[45,161],"2005":[46],"2008":[48],"were":[49,62,101,107,122,131,137,144,152,253],"analysed.":[50],"Patients":[51],"receiving":[52],"at":[53],"least":[54],"one":[55],"prescription":[56],"etanercept":[59,111,163,185,261],"or":[60,70,285],"identified":[63],"categorised":[65],"as":[66,146],"\"TNF":[67,71],"inhibitor":[68,72,79,139,148,168],"naive\"":[69],"continuing\".":[73],"For":[74,192],"calculation":[76],"survival":[82],"analysis":[83],"with":[84,267],"Kaplan-Meier":[86],"estimator":[87],"was":[88,93,179,201,271],"used.":[89],"A":[90,125],"Cox":[91],"regression":[92],"used":[94],"to":[95],"analyse,":[96],"if":[97],"any":[98],"relevant":[99],"factors":[100],"influencing":[102],"persistence.":[103],"Dosage":[104,225],"increase":[105,226],"rates":[106,160],"analysed":[108],"for":[109,166,181,184,188,203,206,210,276,279],"infliximab.":[113],"Sensitivity":[114],"analyses":[115],"based":[116],"variations":[118],"gap":[120],"length":[121],"conducted.":[123],"RESULTS:":[124],"total":[126],"2,201":[128],"RA":[129],"identified.":[132],"1,468":[133],"these":[135],"naive":[140,169,190,236],"733":[143],"defined":[145],"continuing":[149,171,193,246],"patients.":[150,172,191,247,265],"There":[151],"no":[153,254],"significant":[154,255],"differences":[155,256],"treatment":[158],"The":[173],"rate":[175,197],"after":[176,198],"three":[177,199],"years":[178,200],"22.47%":[180],"24.27%":[183],"21.49%":[187],"patients,":[194],"32.88%":[202],"30.95%":[205],"33.90%":[209],"infliximab,":[211],"respectively.":[212],"Gender,":[213],"medication":[214],"Charlson":[216],"Comorbidities":[217],"Index":[218],"did":[219],"not":[220],"influence":[221],"significantly.":[224],"occurred":[227],"7.3%":[229],"1.4%":[231],"17.2%":[234],"5.8%,":[239],"1.1%":[240],"11.9%":[242],"respectively":[243],"CONCLUSIONS:":[248],"study,":[251],"there":[252,270],"among":[259],"Consistent":[266],"previous":[268],"research,":[269],"higher":[273],"dose":[274],"escalation":[275],"than":[278],"two":[281],"subcutaneous":[282],"treatments,":[283],"adalimumab":[284],"etanercept.":[286]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}